Related references
Note: Only part of the references are listed.Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2018
DIABETES CARE (2018)
Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus 10-Year Follow-Up of a Randomized Controlled Trial
Yoshihiko Saito et al.
CIRCULATION (2017)
Hypoglycemia and Medical Expenses in Patients with Type 2 Diabetes Mellitus: An Analysis Based on the Korea National Diabetes Program Cohort
Sang Youl Rhee et al.
PLOS ONE (2016)
A Comparison of Ultrasound Intima-Media Thickness Measurements of the Left and Right Common Carotid Artery
Christos P. Loizou et al.
IEEE JOURNAL OF TRANSLATIONAL ENGINEERING IN HEALTH AND MEDICINE (2015)
The efficacy and safety of cilostazol in ischemic stroke patients with peripheral arterial disease (SPAD): protocol of a randomized, double-blind, placebo-controlled multicenter trial
Jiann-Shing Jeng et al.
INTERNATIONAL JOURNAL OF STROKE (2015)
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis
F. Gerald R. Fowkes et al.
LANCET (2013)
Cilostazol Prevents Endothelin-Induced Smooth Muscle Constriction and Proliferation
Yoshifumi Kawanabe et al.
PLOS ONE (2012)
Side Differences of Carotid Intima-Media Thickness in Predicting Cardiovascular Events Among Patients With Coronary Artery Disease
Stephen Wai-luen Lee et al.
ANGIOLOGY (2011)
Differences in left and right carotid intima-media thickness and the associated risk factors
X. Luo et al.
CLINICAL RADIOLOGY (2011)
25-Hydroxyvitamin D Deficiency Is Associated With Inflammation-Linked Vascular Endothelial Dysfunction in Middle-Aged and Older Adults
Kristen L. Jablonski et al.
HYPERTENSION (2011)
Prevalence of Chronic Complications in Korean Patients with Type 2 Diabetes Mellitus Based on the Korean National Diabetes Program
Sang Youl Rhee et al.
DIABETES & METABOLISM JOURNAL (2011)
Does Vitamin D Modulate Asymmetric Dimethylarginine and C-Reactive Protein Concentrations?
Doan T. Ngo et al.
AMERICAN JOURNAL OF MEDICINE (2010)
The Phosphodiesterase Inhibitor Cilostazol Induces Regression of Carotid Atherosclerosis in Subjects With Type 2 Diabetes Mellitus Principal Results of the Diabetic Atherosclerosis Prevention by Cilostazol (DAPC) Study: A Randomized Trial
Naoto Katakami et al.
CIRCULATION (2010)
Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults
R. D. Semba et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2010)
Effect of Vitamin D Deficiency and Replacement on Endothelial Function in Asymptomatic Subjects
Ozlem Tarcin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Prospective Study of Serum 25-Hydroxyvitamin D Level, Cardiovascular Disease Mortality, and All-Cause Mortality in Older US Adults
Adit A. Ginde et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2009)
Antiplatelet cilostazol is beneficial in diabetic and/or hypertensive ischemic stroke patients
Yukito Shinohara et al.
CEREBROVASCULAR DISEASES (2008)
Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels
J. A. Sugden et al.
DIABETIC MEDICINE (2008)
Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes A Randomized Controlled Trial
Hisao Ogawa et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease
Jill Belch et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
AHA/ADA vs. ESC/EASD recommendations on aspirin as a primary prevention strategy in people with diabetes: how the same data generate divergent conclusions
Antonio Nicolucci et al.
EUROPEAN HEART JOURNAL (2007)
Lack of difference in the intimal medial thickness between the left and right carotid arteries in the young
Y. Arbel et al.
ACTA NEUROLOGICA SCANDINAVICA (2007)
Mineral metabolism and arterial functions in end-stage renal disease:: Potential role of 25-hydroxyvitamin D deficiency
Gerard M. London et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Reduction of remnant lipoprotein cholesterol concentrations by cilostazol in patients with intermittent claudication
T Wang et al.
ATHEROSCLEROSIS (2003)
A phosphodiesterase inhibitor, cilostazol, prevents the onset of silent brain infarction in Japanese subjects with Type II diabetes
T Shinoda-Tagawa et al.
DIABETOLOGIA (2002)
Decrease in carotid intima media thickness after 1 year of cilostazol treatment in patients with type 2 diabetes mellitus
CW Ahn et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2001)
Antiplatelet drugs attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes
M Kodama et al.
THROMBOSIS RESEARCH (2000)
Share Paper
